Category Archive

Pfizer essentially confirming Omicron is mild = Omicron needs to be “repriced” in financial marketsPfizer’s CEO, Albert Bourla, told the WSJ yesterday that Omicron does appear milder and this is another positive anecdote. Symptoms from Omicron appearing milder This is consistent with many health experts who have argued virus gain transmissibility but trade-off tends to be lethality This is still …

Markets were roiled by the Facebook earnings miss this week. The stock declined around 26% yesterday in response which was the largest single-day decline of market-cap ever. Despite the market’s harsh reaction to that big miss, we still see the most likely outcome as a violent upside rally in February 2022. Remember we went over three reasons why we say …